Eli Lilly and Company
Eli Lilly discovers, develops, manufactures, and sells prescription medicines. Its products cover diabetes and obesity, oncology, immunology, and neuroscience. Mounjaro and Zepbound, both based on the drug tirzepatide, account for a majority of its revenue (for the nine months ended September 30, 2026), and the company also sells Foundayo, an oral obesity medicine approved in 2026. Lilly reports as a single segment, human pharmaceuticals. Colonel Eli Lilly founded the company in 1876, and it is headquartered in Indianapolis, Indiana.
Connect and whitelist your wallet on Securitize and start trading LLY tokens instantly.
Go to TradingTradeable assets will be available on leading DeFi protocols.
Eli Lilly discovers, develops, manufactures, and sells prescription medicines. Its products cover diabetes and obesity, oncology, immunology, and neuroscience. Mounjaro and Zepbound, both based on the drug tirzepatide, account for a majority of its revenue (for the nine months ended September 30, 2026), and the company also sells Foundayo, an oral obesity medicine approved in 2026. Lilly reports as a single segment, human pharmaceuticals. Colonel Eli Lilly founded the company in 1876, and it is headquartered in Indianapolis, Indiana.
Connect and whitelist your wallet on Securitize and start trading LLY tokens instantly.
Go to Trading